Takeda to build €100M+ dengue vaccine plant in Singen, Germany

Takeda Pharmaceuticals announced it will invest more than 100 million euros to build a new manufacturing plant for its dengue vaccine candidate in Singen, Germany. Initial construction will start immediately, and the facility should be ready for production in 2019.

“This manufacturing plant investment reinforces Takeda’s strong support for our global vaccine strategy in general, and dengue in particular.”takeda.com

• 1 source
• takeda.comTakeda to invest more than 100 Million Euros in Dengue Vaccine Manufacturing plant in GermanyTakeda Pharmaceutical Company LimitedNov 30, 2016

Summarized from public sources; check the original articles before acting on it.